ADULT DIAPER - RFID PAPER
Invented and patented by Pitney Bowes, this technology uses paper and ink connected to an RFID chip to send a signal. After a review in the summer of 2012, it was determined that this technology may hold the answer to a vexing problem in the Nursing Home industry where over 60% of the nursing home residents are incontinent. Health and safety regulations require that the nursing home staff check the status of the residents adult diaper regularly throughout the day and night. At this time the only way to accurately check the status is a manual check that is disruptive and humiliating. To maximize the protection of this idea, the IP Factory has filed a provisional patent with the US Patent Office. The IP Factory is actively seeking licensing partner(s) for this first product opportunity.
Based on the revenue stream from this license the IP Factory will start a company to pursue the other product ideas that came from the commercialization review. Besides a series of other products that come from the moisture detection system, this technology can be used in data detection on forms for surveys, etc.
SIGNITSURE - MULTISPECTRAL ENCODED TAG
After years of effort to assist the U.S. Postal Service in its processing of mail, Pitney Bowes was able to invent and patent a black ink that when exposed to florescent light would emit a different color. After review by the Analytic Team to determine the best commercial use cases for the technology, the IP Factory incorporated its first company, SignitSure. Given the nature of the ink, commercial concepts around securing documents was the highest recommended area to pursue. The first product to be launched by SignitSure is the ScriptID system that performs prescription verification. Early stage money to finalize the Business Plan and market research has been applied for and it is expected that ScriptID systems will be in use in 2014.
Customer Communications Portal
Over the years, Pitney Bowes has been able to develop a number of business communications solutions for its business clients utilizing a set of proprietary and non proprietary software. Pitney Bowes asked the IP Factory to review how this suite of technologies could be used to develop products for the public sector. In May 2013, the Analytic Team determined a number of potential uses for these technologies and recommended that we focus on an early win to get a revenue stream to start a company that could then pursue the other recommended commercialization options.
The first product, SecureBar, is designed to relieve Bar applicant of the significant burden in collecting the materials needed in the character and fitness portion of the bar exam application. The amount of information requested is significant and sometimes difficult to retrieve by these 3rd year law students who are simultaneously trying to finish their studies. SecureBar provides a simple secure method for collecting and storing the information. We believe that once launched this same solution can be adapted to other professional areas such as doctors and teachers who require extensive background checks.
Absorbable Gastric Band
Initially invented by Sofradim, a French company acquired by Covidien, this product did not fit into Covidienís product mix. The IP Factoryís review revealed that although traditional gastric banding was losing favor as a technique to control or reverse obesity, this product responded to many of the negatives with the traditional bands. Based on a globally growing problem with obesity it was felt that there was a significant market for this product. In addition, the absorbable polymer lends itself to other products that could be used in the body.
The IP Factory is currently determining the clinical development plan for a product launch in Europe and also the United States. With revenue coming in from non-US sales, a newly formed company can pursue the clinical trials that are needed for US approval as well as looking at other products for which the absorbable polymer could serve as the base.
a technology which shows promise in the area of wound healing as demonstrated
by increased breaking strength in non-human clinical studies. The IP
Factory is exploring the path to market through development of a business
plan. It was determined that although commercialization was possible,
the remaining time of patent protection was too short to justify investment.